Innomedica was established in 1997. Since then, we have provided our services to more than 250 pharmaceutical, biotechnology, diagnostics and medical device companies in Europe, Japan and the USA. We have offices in Helsinki, Stockholm and Tokyo.
We are proud to stand behind our words. Innomedica is a company with employees – not a network of individual consultants. This means we are fully committed to the high standards and professionalism at Innomedica. We have a quality system for our service production in place and we take full responsibility for the work we provide. We work in teams for each client assignment, providing you with efficient and timely results.
127 million population covered by national insurance and with the one of the highest GDPs in the world
National medical spending in Japan is 420 billion USD
9000 hospitals and 100 000 clinics
Six of the top ten multinational pharmaceutical companies are European
Many of the leading medical device companies are European, such as Siemens Healthcare and Philips Healthcare
Largest healthcare markets in Europe are Germany, UK, France, Italy and Spain
Demographic change, aging population and falling birth rates, combined with the need to cut costs puts pressure on healthcare
The budget for the Horizon 2020 is estimated to be 70 billion euros. The new program will focus on three pillars:
The preparation is ongoing and commission is collecting inputs via public consultation and from the technology platforms. The estimated launch for Horizon 2020 is by the end of 2013.
- Competitive Industries,
- Excellent Science and
- Better Society.
• Innomedica Market Analysis sums up literature and expert interviews to understand your market opportunity.
• Knowledge is a quick market feasibility study that includes patentability analysis. A perfect tool for technology transfer offices and research institutes. More on Knowledge (pdf).
• OnPoint market intelligence platform keeps your management team on top of the market, effortlessly and cost-efficiently. If you are a company with several products on international markets, OnPoint is your best choice.
Innomedica abide to the European Standard EN 16114:2011 Management consultancy services.
All Innomedica team members have PhDs or MScs in life science related areas and an average of 20 years of experience in the services we provide.
Our internal training program Innomedica Academy provides us with continuous learning and professional development.
Copyright 2016 All Rights Reserved Terms and conditions
Back to Top